Benzinga's Top Upgrades By: Benzinga via Benzinga September 08, 2014 at 08:54 AM EDT Analysts at Goldman Sachs upgraded Vertex Pharmaceuticals (NASDAQ: VRTX) from Neutral to Buy. The target price for Vertex ... Read More >> Related Stocks: Infinera Corp L-3 Communications Holdings Matrix Service Company Vertex Pharmaceuticals